About Strawberry Banana
SBIndica HybridStrawberry Banana is a cross between two fruity strains: Bubblegum and Banana Kush.
Bred by DNA Genetics (Reserva Privada)
Although Strawberry Banana seems like a taste combination best suited to a breakfast smoothie, it’s also the name of an indica-leaning hybrid developed by breeders DNA Genetics in collaboration with Serious Seeds. Strawberry Banana is a cross between two fruity strains: Bubblegum and Banana Kush. With a universally-appealing flavour, this strain enjoys wide popularity in the U.S. west coast market.
To top it all off, cannabis testing lab Analytical 360 has consistently found flowers of Strawberry Banana to have between 17% and 23% THC. In 2018 Emerald Cannabis Worx LLC contacted Wikileaf with a report of their lab testing results by Green Leaf Labs. The report boasted a whopping 32.61% Total THC for their variant of Strawberry Banana.
Strawberry Banana has small to medium-sized flowers that maintain a tight, dense bud structure - the tightly-packed leaves do not come easily off of their central stems. The leaves themselves appear light green with a yellowish tint and are set off by bright orange pistils. Some phenotypes of this strain are also flecked with purple, the result of pigments in the plant’s genetics being stimulated by colder-than-average temperatures during the growing process. A furry coating of white trichomes covers the flowers and accounts for their high THC.
When properly cured, flowers of this strain have a sweet and mildly fruity taste, more like banana than strawberry. Breaking open or grinding the buds yields a more hashy, spicy scent, betraying this strain’s OG Kush roots. Strawberry Banana offers a smooth, easy smoke when combusted and tastes distinctly like berries on the exhale. And while it may leave behind a fruity, creamy sensation, Strawberry Banana is also very pungent, so those trying to keep their consumption discreet should take caution.
Description provided by Wikileaf.
Information provided could come from a third-party source, and may not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About Somai Pharmaceuticals Inc
Somaí, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specialising in cannabinoid-based medicines, is driving the global pharmaceutical cannabis market with a broad portfolio of EU-GMP-certified extracts.
Somaí is building a global brand focused on innovative cannabis-based therapeutics, with a vision of people living healthier lives supported by natural cannabis medicines.
The core strength of Somaí lies in its EU-GMP certification, which represents the gold standard for pharmaceutical manufacturing worldwide. This is particularly important in markets like the U.K., where there is a clear distinction between fully EU-GMP pharmaceutical products and less stringently regulated “Specials” or compounded extracts.
Somaí owns and operates its facilities under this highest standard:
- Somaí Pharmaceuticals – a state-of-the-art manufacturing facility in Lisbon, Portugal
- NovaSoma – an indoor cultivation facility, also in Lisbon, Portugal
Complete vertical integration—from indoor cultivation through to finished-dose manufacturing—under strict EU-GMP rules ensures batch-to-batch consistency, long-term stability data, and chemical reproducibility for patients. This level of quality and regulatory adherence allows Somaí's products to be supplied globally as true finished-dosage pharmaceutical extracts.
This commitment to the EU-GMP pharmaceutical standard enables Somaí to compete directly with established pharmaceutical manufacturers and to build one of the most advanced certified cannabinoid-containing extract portfolios worldwide.
somaipharma.eu